New breakthroughs in diabetic diagnosis, cardiology and gene therapy were highlighted at a recent healthcare symposium in Beirut.

Beirut based Clemenceau Medical Center (CMC) affiliated with US-based Johns Hopkins Medicine International hosted the second Johns Hopkins Internal Medicine Symposium with the participation of international and local experts.

The symposium discussed the latest updates in preoperative assessment, diabetes guidelines, genomic medicine in primary care, and interactive clinical problem solving.

It revealed that “glycosylated hemoglobin” could now be used in the diagnosis of diabetes or pre-diabetic stage, in addition to being a marker for follow up.

Another finding emphasized that cardiac catheterization for preoperative clearance is not a necessity while echocardiography is a need for patients with cardiac problems and high risk family history.

Participants also agreed that the study of patients’ genes in medical diagnosis and how the design of gene therapy can be useful in the treatment of specific and non-specific illnesses.

“Based on the remarkable success of the previously held Johns Hopkins Internal Medicine Symposium, we have come to recognize the necessity to revisit more updates and recommendations from the world’s best experts of Johns Hopkins International,” said Dr Mounes Kalaawi, chief executive officer of CMC hospital. – TradeArabia News Service